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1Letter by Pyrogianni and La Vecchia 
Regarding Article, “Artificially Sweetened 
Beverages and Stroke, Coronary Heart Disease, 
and All-Cause Mortality in the Women’s  
Health Initiative”
To the Editor:
Mossavar-Rahmani et al1 reported an association between 
artificially sweetened beverages (ASBs; ≥2 per day) and stroke, 
coronary heart disease, and all-cause mortality in a cohort of 
81 714 postmenopausal US women from the Women’s Health 
Initiative Observational Study.
However, residual confounding is a key issue in that study. 
Women reporting consumption of ≥2 ASBs per day were more 
frequently obese, hypertensive, current or past smokers, with a 
history of diabetes mellitus and cardiovascular disease. Table 2 
shows a drastic fall in the hazard ratios after allowance for covari-
ates, which suggests that more precise and valid adjustment for 
confounding would likely result in a further decrease of the as-
sociation. The hazard ratio for stroke declined from 1.59 to 1.23 
after multivariate analysis, that of coronary heart disease from 
1.94 to 1.29, and total mortality from 1.53 to 1.16. In addition, 
there was no trend in risk with dose. Only 5.1% of women re-
ported an intake of ≥2 ASBs per day. This may well introduce 
selection bias. The association with stroke was stronger for black 
women (114 events in total), but the number of events in Black 
women consuming ≥2 ASBs per day is likely to be very small, 
and hence selection bias becomes a serious issue. Further, the use 
of a nonvalidated questionnaire for assessing ASBs consumption 
makes information bias difficult to quantify.
With regard to mechanisms, a systematic review by Toews 
et al,2 commissioned by the WHO, found no evidence that low-
calorie sweeteners (LCS) have adverse effects on major cardio-
vascular disease risk factors. They indeed found a small beneficial 
effect of LCS on body mass index and fasting blood glucose. 
When used to replace sugars, LCS help in total energy intake re-
duction and in modest weight loss.3
Randomized controlled trials showed that systolic and dias-
tolic blood pressure, the major risk factor for stroke, were either 
lower or unaffected with LCS intake, compared with sugar or pla-
cebo.2 In addition, other randomized controlled trials that have 
investigated higher intakes of ASBs of 1 L/d or more for 6 months 
found favorable effects on liver and vascular fat, and no material 
impact on glycemia, blood cholesterol, and triglyceride levels.4
Thus, the current evidence supports no plausible mechanism 
of how ASBs could increase the risk of stroke, coronary heart 
disease, or other cardiovascular disease in humans. Data from 
both observational studies and randomized controlled trials in-
dicate that LCS do not negatively affect risk factors linked to 
cardiovascular disease, including blood pressure, blood lipids 
levels, glycemia, or body weight.2–4 Other potential mechanisms 
discussed by Mossavar-Rahmani et al, and which stem prima-
rily from animal studies, have not been confirmed in humans.5 
Therefore, selection, reverse causation and, mainly, residual con-
founding may partly or largely explain the reported associations.
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